What You Should Know:
– KēlaHealth announced their Series A round (combined seed and Series A) of $12.9M led by Sante Ventures and new innovation VC, Intuitive Ventures.
– KēlaHealth, is a surgical intelligence engine that applies a dynamic cycle of patient-specific predictions, stratified interventions, and outcomes tracking to reduce surgical complications
– KēlaHealth is the first investment for Intuitive Ventures, a new innovation fund spun out of Intuitive Surgical, Inc.
KēlaHealth, Inc., a San Francisco, CA-based surgical intelligence platform that applies a dynamic cycle of patient-specific predictions, stratified interventions, and outcomes tracking to reduce surgical complications, today announced the closing of a $2.9 million Seed financing and milestone-based $10 million Series A financing led by Santé Ventures and Intuitive Ventures, and inclusive of grant funding from the National Science Foundation Small Business Innovation Research (SBIR) Program. These funds will accelerate the expansion of the KēlaHealth platform to hospitals and surgical partners across the United States. KēlaHealth is the first investment for Intuitive Ventures, a new innovation fund spun out of Intuitive Surgical, Inc.
Learning Ecosystem to Improve Surgical Care Outcomes
Founded by Bora Chang, MD, with a goal of harnessing machine learning algorithms to reduce patient surgical complications and improve outcomes. KēlaHealth uses advanced artificial intelligence techniques to deliver a cloud-based software-as-a-service solution to healthcare providers, surgeons, and hospital systems.
In the U.S., 51 million surgeries are performed annually, with an average complication rate of 15 percent. This results in millions of patients suffering harm and loss after a procedure. Tragically, half of these complications are known to be avoidable and contribute to $77 billion in wasted healthcare costs each year
KēlaHealth helps to prevent these avoidable complications while enhancing surgical care by delivering stratified patient risk scoring. The company’s state-of-the-art platform uses machine learning algorithms to match individual risk levels with graduated pathways of care that align with the unique needs of each surgical patient.
These personalized efforts bring surgery into a new era of precision medicine: with KēlaHealth, surgeons can match the right patient with the right procedure with the right precautions at the right time, leading to improved patient outcomes and significant hospital savings.
To date, KēlaHealth’s hospital partners have applied the company’s AI-powered platform in colorectal, vascular, cardiac, and orthopedics surgical specialties.
The company has participated in highly selective accelerator programs such as Cedars-Sinai Techstars Accelerator, Healthbox Studio, and Plug and Play.
Dr. Chang, CEO of KēlaHealth added: “Our vision is to apply the lessons learned from millions of previous surgeries for the benefit of every patient undergoing a procedure. Patients and their families, clinicians, and hospitals deserve the assurance that the risks of any surgery will be safely navigated by surgical teams with the best information available to them at every point in the surgical journey. We are thrilled to have a stellar group of surgeons, hospital centers, investors, and advisors working with us to realize the opportunity of precision surgery.”
